Author(s) :

Monica-Emilia.

Volume/Issue :

Abstract :

Dr. Anna Kirby is the ESTRO President-Elect and a Consultant Clinical Oncologist working at the Royal Marsden and Institute of Cancer Research, UK. She specialises in the treatment of patients with breast cancer and leads research into novel breast radiotherapy techniques. She is Chief Investigator of the UK HeartSpare and HeartSpare Plus studies, and breast lead investigator on the UK CORE trial evaluating the role of stereotactic radiotherapy in treating metastatic disease. Dr. Kirby graduated from Cambridge University in 1995 with a first-class honours degree in Medicine and Psychology. Her specialist oncology training was completed at The Royal Marsden and Guy’s and St Thomas’ Hospitals following which she undertook a research degree at the Institute of Cancer Research.

No. of Downloads :

0